A new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets – Innovation Toronto

Gold nanostars have emerged as promising drug-delivery agents that can be designed to target cancer cells

Targeting nanoparticles rotate faster and move across larger areas

Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.

A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply analyzing each nanoparticle’s distinct movements in real time.

By studying drug-loaded gold nanostars on cancer cell membranes, the researchers found that nanostars designed to target cancer biomarkers transited over larger areas and rotated much faster than their non-targeting counterparts. Even when surrounded by non-specifically adhered proteins, the targeting nanostars maintained their distinct, signature movements, suggesting that their targeting ability remains uninhibited.

“Moving forward, this information can be used to compare how different nanoparticle characteristics — such as particle size, shape and surface chemistry — can improve the design of nanoparticles as targeting, drug-delivery agents,” said Northwestern’s Teri Odom, who led the study.

The study published today (Aug. 9) in the journal ACS Nano. Odom is the Charles E. and Emma H. Morrison Professor of Chemistry in Northwestern’s Weinberg College of Arts and Sciences.

The medical field has long been searching for alternatives to current cancer treatments, such as chemotherapy and radiation, which harm healthy tissues in addition to diseased cells. Although these are effective ways to treat cancer, they carry risks of painful or even dangerous side effects. By delivering drugs directly into the diseased area — instead of blasting the whole body with treatment — targeted delivery systems result in fewer side effects than current treatment methods.

“The selective delivery of therapeutic agents to cancer tumors is a major goal in medicine to avoid side effects,” Odom said. “Gold nanoparticles have emerged as promising drug-delivery vehicles that can be synthesized with designer characteristics for targeting cancer cells.”

Various proteins, however, tend to bind to nanoparticles when they enter the body. Researchers have worried that these proteins might impede the particles’ targeting abilities. Odom and her team’s new imaging platform can now screen engineered nanoparticles to determine if their targeting function is retained in the presence of the adhered proteins.

Learn more: Nanoparticles’ movement reveals whether they can successfully target cancer

August 10, 2019 – Way developed to determine effectiveness of drug-delivery nanoparticles: study – Xinhua | English.news.cn  XinhuaCHICAGO, Aug. 10 (Xinhua) — Researchers at Northwestern University (NU) have developed a way to determine whether or not single drug-delivery …

August 9, 2019 – Nanoparticles’ movements reveal whether they can successfully target cancer: Targeting nanoparticles rotate faster and move across larger areas  Science DailyResearchers have developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply …

August 9, 2019 – Advances in nanocarriers as drug delivery systems in Chagas disease | IJN  Dove Medical PressChristian Quijia Quezada,1,2 Clênia S Azevedo,1 Sébastien Charneau,3 Jaime M Santana,1 Marlus Chorilli,2 Marcella B Carneiro,4 Izabela Marques Dourado …

July 30, 2019 – Magnetic Fields and Nanoparticles to Improve Cancer Treatment  Advanced Science NewsCurrent approaches to treating cancer can result in severe side effects due to the undesirable impacts of chemotherapeutic drugs. To minimize this toxicity, …

August 8, 2019 – Capping gold nanoparticles with albumin to improve their biomedical pr | IJN  Dove Medical PressKaren Bolaños,1–3 Marcelo J Kogan,2,3 Eyleen Araya1,2 1Departamento de Ciencias Quimicas, Facultad de Ciencias Exactas, Universidad Andres Bello, …

July 17, 2019 – Global Pruritus Drugs Market 2019-2023 | Nanoparticle-Enabled Transdermal Drug Delivery Systems to Boost Growth | Technavio  Tullahoma News and GuardianLONDON–(BUSINESS WIRE)–Jul 17, 2019–. The global pruritus drugs market is expected to post a CAGR of over 5% during the period 2019-2023, according …

via Google News

The Latest on: Drug-delivery nanoparticles

A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply analyzing each … […]

CHICAGO, Aug. 10 (Xinhua) — Researchers at Northwestern University (NU) have developed a way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended … […]

A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets—by simply analyzing … […]

SP-sLip preserve functions of the absorbed human plasma ApoE, and the corona-mediated targeting strategy works in SP modified PLGA nanoparticles. The present study may pave a new avenue to facilitate … […]

Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described. Transdermal technologies … […]

Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin patch … […]

Bio-Synectics’ highly useful drug delivery system solution has ensured better efficacy … Wet milling is a top-down approach in the production of nanoparticles. In this process, the raw material is … […]

The global pruritus drugs market is expected to post a CAGR of over 5% during the period 2019-2023, according to the latest market research report by Technavio. This press release features multimedia. … […]

This is the area of focus for new research from MIT, where engineers have designed tiny robots that can help drug-delivery nanoparticles push their way directly into a tumor or another disease site, … […]

via  Bing News